{"SPADE_UN_15500": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15500", "Peptide Name": "Wollamide B [L2Me-Leu, V4Me-Val]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "WXLXNX", "Sequence Length": 6, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HepG2 (IC50>100ÂµM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C15H10N4", "Mass": 55563, "PI": 6.11, "Net Charge": 0, "Hydrophobicity": -0.733, "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent", "Pubmed ID": "28423019", "Reference": "PLoS One. 2017 Apr 19;12(4)e0176088.", "Author": "Asfaw H, Laqua K, Walkowska AM, Cunningham F, Martinez-Martinez MS, Cuevas-Zurita JC, Ballell-Pages L, Imming P.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28423019"}], "Frequent Amino Acids": "XLN", "Absent Amino Acids": "ACDEFGHIKMOPQRSTUVY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 1, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00054", "Similarity": 1.0, "Sequence": "AGFLKVVQLLAKYGSKAVQWAWANKGKILDWLNAGQAIDWVVSKIKQILGIK"}, {"SPADE_ID": "SPADE_N_00056", "Similarity": 1.0, "Sequence": "MSWLNFLKYIAKYGKKAVSAAWKYKGKVLEWLNVGPTLEWVWQKLKKIAGL"}, {"SPADE_ID": "SPADE_N_02099", "Similarity": 1.0, "Sequence": "GWFKKAWRKVKHAGRRVLDTAKGVGRHYLNNWLNRYRG"}]}}}